ERT, Bioclinica: renamed to Clario
Following endpoint specialist ERT’s merger earlier this year with Bioclinica (a medical imaging firm), the combined company has been rechristened Clario. According to the leadership of the newly renamed company, it will focus on clinical trial innovation and improving healthcare.
"Clario is much more than the merger of two companies," said CEO Joe Eazor. "We have combined decades of scientific expertise and unrivaled global scale to create the broadest endpoint technology platform poised to expedite the clinical trial process, simplify trial experiences and unlock composite endpoints.”